merged_engineered-virus-steals-proteins-from-hiv.txt
<other>Analyzing the article to answer the questions based solely on the provided information.</other>

<question_number>1</question_number>
<answer>One shot of TIPs may keep H.I.V. at low levels permanently, unlike lenacapavir which requires twice-yearly shots.</answer>

<question_number>2</question_number>
<answer>It might make it harder for people to transmit H.I.V. to others.</answer>

<question_number>3</question_number>
<answer>TIPs become a permanent part of the patient's body, raising concerns about consent for those who might be secondarily infected.</answer>

<question_number>4</question_number>
<answer>TIPs interfere with H.I.V.'s life cycle by outcompeting the virus in infected cells, unlike protease inhibitors which target specific viral proteins.</answer>

<question_number>5</question_number>
<answer>Unexpected side effects that cannot be reversed due to TIPs becoming a permanent part of the body.</answer>

<question_number>6</question_number>
<answer>TIPs produce three times more particles than H.I.V. in infected cells, allowing them to outcompete the virus.</answer>

<question_number>7</question_number>
<answer>Unexpected side effects that cannot be removed from the body.</answer>

<question_number>8</question_number>
<answer>In principle, it could be applied to other viruses using the same strategy.</answer>

<question_number>9</question_number>
<answer>Doctors cannot obtain consent from individuals who might be secondarily infected by TIPs.</answer>

<question_number>10</question_number>
<answer>TIPs interfere with H.I.V.'s replication by outcompeting it, while protease inhibitors target specific viral proteins.</answer>